Brigitte Wildemann

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

Sven Jarius, Klemens Ruprecht, Ingo Kleiter et al. · Journal of Neuroinflammation · 2016 · 891 citations · Full text

Medicine, Neurology, Neuroscience +15

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Sven Jarius, Klemens Ruprecht, Brigitte Wildemann et al. · Journal of Neuroinflammation · 2012 · 764 citations · Full text

Life Sciences, Immunology, Neurology +9

Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients

S. Schwarz, Alexander Mohr, Michael Knauth et al. · Neurology · 2001 · 511 citations

Medicine, Neurology, Neuroscience +14

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis

Jürgen Haas, Andreas Hug, Andrea Viehöver et al. · European Journal of Immunology · 2005 · 444 citations

Life Sciences, Immunology, Neurology +17